Questions and Answers on RTS,S/ASO1 Malaria Vaccine

This web page provides answers to frequently asked questions about the RTS,S/AS01 (RTS,S) malaria vaccine, the world’s most advanced malaria vaccine candidate. RTS,S was developed through a partnership between GlaxoSmithKline Biologicals and the PATH Malaria Vaccine Initiative, with support from the Bill & Melinda Gates Foundation and a network of African research centers.

Author: World Health Organization

Published: 2016

» Visit web page (English)

(Located at

Resource types: Website

Diseases/vaccines: Malaria

Topics: Vaccine safety and performance, Disease/vaccine specific information

Regions: Global